Skip to Content

Tag: CPAP recall

Mick Farrell


ResMed makes dent in $300M goal

October 29, 2021Liz Beaulieu, Editor

SAN DIEGO – ResMed posted a 40% increase in sales for CPAP devices in the U.S., Canada and Latin America in the first quarter of the company’s fiscal year 2022, driven in part by increased demand created by a competitor’s recall.  Company officials previously said they expect the recall to result in incremental revenue from device sales of $300 million to $350 million for fiscal year 2022 but meeting that goal will depend on their ability to address supply chain issues.  “We...

CPAP Machines, CPAP recall, ResMed

Read Full Articlered right arrow icon